Journal
IJC METABOLIC & ENDOCRINE
Volume 5, Issue -, Pages 19-23Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijcme.2014.08.007
Keywords
Cardiac magnetic resonance; Diabetic cardiomyopathy; Microvascular coronary dysfunction
Categories
Funding
- Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award
- Centre of Excellence in Medical Engineering - (Wellcome Trust) [WT 088641/Z/09/Z]
- Centre of Excellence in Medical Engineering - (EPSRC) [WT 088641/Z/09/Z]
- BHF Centre of Excellence (British Heart Foundation) [RE/08/03]
- Philips Healthcare
- Bayer Schering Pharma and Philips Healthcare
Ask authors/readers for more resources
Background: Diabetic cardiomyopathy is characterized by microvascular disease and interstitial fibrosis, which lead to progressive heart failure; however, its pathogenesis remains uncertain. Perfusion cardiac magnetic resonance (CMR) has been proven efficient to detect subclinical myocardial perfusion reserve abnormalities in context of diabetes type 1 in the absence of epicardial coronary artery disease. Objective: To evaluate myocardial perfusion reserve in patients with advanced cardiomyopathy and type 2 diabetes mellitus but without obstructive coronary artery disease (DM2). We hypothesized that impaired myocardial perfusion reserve deteriorates as systolic dysfunction progresses. Method and results: Mean myocardial perfusion relative upslope at rest and during hyperaemia (adenosine 140 mg/kg/min) andmean perfusion reserve index (MPRI), were examined in 11 clinically stable DM2 patients (mean (SD) age 67 (8.4) years, range of 54-83 years; NYHA I-II; EF: 37.4 (11.3) %) using perfusion cardiac magnetic resonance (CMR). They were compared against 16 patients with idiopathic cardiomyopathy (mean age: 62 (14.0) years, range of 37-82 years; NYHA I-II; mean EF: 46 (12.3) %) and 10 healthy volunteers with normal ECG and no evidence of cardiac disease (mean age 35 (11.2) years, range of 27-66 years; mean EF: 65 (5.1) %). DM2 patients had lower hyperemic perfusion relative upslope (0.2 (0.07) v.0.31 (0.04) p = 0.001) and MPRI (0.736 (0.233) v. 2.35 (0.284), p = 0.001) compared to healthy subjects. Results of DM2 and DCM patients were similar. MPRI in DM2 patents with moderate LV dysfunction was not different from patients with severe dysfunction. Conclusion: In patients with DM2 myocardial perfusion reserve is markedly decreased, suggestive of microvascular disease. In this small cohort MPRI impairment did not correlate to the LV EF deterioration. (C) 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available